136 related articles for article (PubMed ID: 17261286)
41. Preliminary prospective study of the endocrinology of conception cycles and early pregnancy in women with antiphospholipid syndrome treated with low molecular weight heparin.
Prakash A; Laird S; Li TC; Ledger WL
Fertil Steril; 2006 Jan; 85(1):165-70. PubMed ID: 16412749
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of human chorionic gonadotropin as a replacement for gonadotropin-releasing hormone in ovulation-synchronization protocols before fixed timed artificial insemination in beef cattle.
Burns MG; Buttrey BS; Dobbins CA; Martel CA; Olson KC; Lamb GC; Stevenson JS
J Anim Sci; 2008 Oct; 86(10):2539-48. PubMed ID: 18539821
[TBL] [Abstract][Full Text] [Related]
43. A single serum test for measuring early pregnancy outcome with high predictive value.
Sutton-Riley JM; Khanlian SA; Byrn FW; Cole LA
Clin Biochem; 2006 Jul; 39(7):682-7. PubMed ID: 16765931
[TBL] [Abstract][Full Text] [Related]
44. Fertilization and pregnancy using cryopreserved testicular sperm for intracytoplasmic sperm injection with azoospermia.
Ishikawa T; Shiotani M; Izumi Y; Hashimoto H; Kokeguchi S; Goto S; Fujisawa M
Fertil Steril; 2009 Jul; 92(1):174-9. PubMed ID: 18684442
[TBL] [Abstract][Full Text] [Related]
45. Peri-implantation urinary hormone monitoring distinguishes between types of first-trimester spontaneous pregnancy loss.
Foo L; Johnson S; Marriott L; Bourne T; Bennett P; Lees C
Paediatr Perinat Epidemiol; 2020 Sep; 34(5):495-503. PubMed ID: 32056241
[TBL] [Abstract][Full Text] [Related]
46. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle.
Kahraman K; Berker B; Atabekoglu CS; Sonmezer M; Cetinkaya E; Aytac R; Satiroglu H
Fertil Steril; 2009 Jun; 91(6):2437-44. PubMed ID: 18555238
[TBL] [Abstract][Full Text] [Related]
47. Epithelial human chorionic gonadotropin is expressed and produced in human secretory endometrium during the normal menstrual cycle.
Zimmermann G; Ackermann W; Alexander H
Biol Reprod; 2009 May; 80(5):1053-65. PubMed ID: 19164178
[TBL] [Abstract][Full Text] [Related]
48. Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol?
Schoolcraft WB; Surrey ES; Minjarez DA; Stevens JM; Gardner DK
Fertil Steril; 2008 Jan; 89(1):151-6. PubMed ID: 17482177
[TBL] [Abstract][Full Text] [Related]
49. Serum hyperglycosylated human chorionic gonadotropin to predict the gestational outcome in in vitro fertilization/intracytoplasmic sperm injection pregnancies.
Bersinger NA; Wunder DM; Nicolas M; Birkhäuser MH; Porquet D; Guibourdenche J
Fetal Diagn Ther; 2008; 24(1):74-8. PubMed ID: 18504387
[TBL] [Abstract][Full Text] [Related]
50. Effects of follicle-stimulating hormone and human chorionic gonadotropin on gonadal steroidogenesis in two siblings with a follicle-stimulating hormone beta subunit mutation.
Lofrano-Porto A; Casulari LA; Nascimento PP; Giacomini L; Naves LA; da Motta LD; Layman LC
Fertil Steril; 2008 Oct; 90(4):1169-74. PubMed ID: 17961559
[TBL] [Abstract][Full Text] [Related]
51. Statistically significant changes of antimüllerian hormone and inhibin levels during the physiologic menstrual cycle in reproductive age women.
Wunder DM; Bersinger NA; Yared M; Kretschmer R; Birkhäuser MH
Fertil Steril; 2008 Apr; 89(4):927-33. PubMed ID: 17603052
[TBL] [Abstract][Full Text] [Related]
52. Failing pregnancies of unknown location: a prospective evaluation of the human chorionic gonadotrophin ratio.
Condous G; Kirk E; Van Calster B; Van Huffel S; Timmerman D; Bourne T
BJOG; 2006 May; 113(5):521-7. PubMed ID: 16637896
[TBL] [Abstract][Full Text] [Related]
53. Hyperglycosylated hCG.
Cole LA
Placenta; 2007 Oct; 28(10):977-86. PubMed ID: 17346790
[TBL] [Abstract][Full Text] [Related]
54. Effects of early luteal-phase vaginal progesterone supplementation on the outcome of in vitro fertilization and embryo transfer.
Mui Lam P; Chun Cheung M; Ping Cheung L; Ingrid Lok H; John Haines C
Gynecol Endocrinol; 2008 Dec; 24(12):674-80. PubMed ID: 19172535
[TBL] [Abstract][Full Text] [Related]
55. Impact of luteal phase support on pregnancy rates in intrauterine insemination cycles: a prospective randomized study.
Erdem A; Erdem M; Atmaca S; Guler I
Fertil Steril; 2009 Jun; 91(6):2508-13. PubMed ID: 18692788
[TBL] [Abstract][Full Text] [Related]
56. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
[TBL] [Abstract][Full Text] [Related]
57. Amphiregulin is much more abundantly expressed than transforming growth factor-alpha and epidermal growth factor in human follicular fluid obtained from patients undergoing in vitro fertilization-embryo transfer.
Inoue Y; Miyamoto S; Fukami T; Shirota K; Yotsumoto F; Kawarabayashi T
Fertil Steril; 2009 Apr; 91(4):1035-41. PubMed ID: 18325497
[TBL] [Abstract][Full Text] [Related]
58. Urinary hormone levels at the time of ovulation and implantation.
Lasley BL; Stabenfeldt GH; Overstreet JW; Hanson FW; Czekala N; Munro C
Fertil Steril; 1985 Jun; 43(6):861-7. PubMed ID: 3996630
[TBL] [Abstract][Full Text] [Related]
59. Serum human chorionic gonadotropin level after ovulation triggering is influenced by the patient's body mass index and the number of larger follicles.
Detti L; Mitwally MF; Rode A; Yelian FD; Kruger M; Diamond MP; Puscheck EE
Fertil Steril; 2007 Jul; 88(1):152-5. PubMed ID: 17418834
[TBL] [Abstract][Full Text] [Related]
60. Letrozole co-treatment in infertile women 40 years old and older receiving controlled ovarian stimulation and intrauterine insemination.
Bedaiwy MA; Shokry M; Mousa N; Claessens A; Esfandiari N; Gotleib L; Casper R
Fertil Steril; 2009 Jun; 91(6):2501-7. PubMed ID: 18501899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
